Citi Downgrades Portola Pharmaceuticals (PTLA) to Neutral

August 19, 2016 7:07 AM EDT
Get Alerts PTLA Hot Sheet
Price: $18.57 +3.51%

Rating Summary:
    2 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade PTLA Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Citi downgraded Portola Pharmaceuticals (NASDAQ: PTLA) from Buy to Neutral with a price target of $24.00.

For an analyst ratings summary and ratings history on Portola Pharmaceuticals click here. For more ratings news on Portola Pharmaceuticals click here.

Shares of Portola Pharmaceuticals closed at $20.12 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Citi

Add Your Comment